
In a statement, the company claimed that Sun Pharma transformed from a US$ 1.7 billion organisation focusing on India and…
Quarter performance beat estimates; FY23/24e EPS up 1/3%; target price revised to Rs 1,089; ‘Buy’ retained.
Sun Pharmaceutical Industries’ share price fell 3.5 per cent intraday on Monday, despite a 43 per cent on-year growth in…
Nifty could now be headed towards the next major intermediate support of 14592 in the coming weeks.
Traction in specialty sales was maintained; FY23/24e EPS down 3.3/3.5%; ‘Buy’ retained with revised target price of Rs 1,040
Sun Pharmaceuticals share price fell 2% to hit an intraday low of Rs 856.7 on NSE on Tuesday after the…
For the trend following traders, the support has shifted to 17250/57650 from 17100/57200.
BSE Sensex and NSE Nifty 50 were trading over 1 per cent higher on Monday, on the back of buying…
The near term market direction would continue to be driven by factors like the assembly election outcome, ECB and US…
Commenting on the company’s Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said…
Nifty futures were trading 51.50 points or 0.33 per cent higher at 15,465.50 on Singaporean Exchange in early trade on…
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun…
Nifty futures were trading flat at 15,305 in early trade on Singaporean Exchange, suggesting a cautious opening for BSE Sensex…
The chart pattern suggests that if Nifty 50 index crosses and sustains above 14,700 level it would witness buying which…
The Nifty / Sensex hovering in the range of 14600 to 14400/ 47500-49000 price range and the texture of the…
On a weekly chart, the market has managed to regain the levels of 14750, which is positive in the short…
After rising for the nine consecutive sessions, BSE Sensex and Nifty 50 look to open in the negative territory on…
Sun Pharmaceutical Industries today signed a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel…
The drug has some presence of ‘unknown impurity’, which was manufactured at the company’s Halol facility in Gujarat Around 3.8…
The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore Sun Pharmaceutical…
NCDs will be listed on BSE under two series Sun Pharmaceutical Industries has raised Rs 1,000 crore through issuance of…
The company expects a re-inspection by US FDA Sun Pharmaceutical Industries has received a warning letter from the US FDA…
Loading…
Something went wrong. Please refresh the page and/or try again.